CD38 and Miyoshi myopathy: Triple-class refractory multiple myeloma (TCR MM) is defined as unresponsiveness to at least one proteasome inhibitor (PI), immunomodulatory drug (IMiDs), or anti-CD38 monoclonal antibody (MoAbs) [3].